medigraphic.com
ISSN 2448-8747 (Print)
Publicación cuatrimestral editada por la Secretaría de Salud Jalisco

2021, Number 2

<< Back Next >>

Sal Jal 2021; 8 (2)

Evaluación de sarcopenia en mujeres: estudio en un grupo de convivencia institucional

Flores-Silva FA, García de Alba-García JE, Salcedo-Rocha AL

Language: Spanish
References: 22
Page: 85-90
PDF size: 330.10 Kb.


ABSTRACT

Sarcopenia is a skeletal muscle illness characterized by accelerated loss of muscle mass and low muscle function. The EWGSOP2 defines it as a progressive and generalized skeletal muscle disorder associated with increase in falls, fractures, physical disability and mortality. It commonly affects older adults, and is more frequently found in women. In Mexico, sarcopenia is relevant due to an accelerated process of population ageing that increases the older adults population. Objective: To determine the prevalence of sarcopenia among the women pertaining to the Dulces Amigos group at the Social, Epidemiological and Health Services Research Unit. Material and methods: The diagnostic criteria for sarcopenia, updated by the EWGSOP2 in 2018, were used to evaluate the presence of sarcopenia in women of 58 years or older, members of the Dulces Amigos group at the UISESS. Results: A prevalence of sarcopenia of 0 was found amongst the group. There was significative association between physical activity and a normal result in the SPPB result (p<0.05). There was no significative association found between BMI and SPPB result. Conclusions: Sarcopenia is a progressive skeletal muscle disorder affecting older people that can be prevented with physical activity and nutritional interventions. Public policies are needed to support healthy and active ageing, as well as screening for conditions like sarcopenia and frailty in older adults assisting the first level of attention.


REFERENCES

  1. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636-46.

  2. Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc [Internet]. 2019 [Consultado 1 Mar 2020]; 21(3):300-307. e2. Disponible en: https://doi.org/10.1016/j.jamda.2019.12.012

  3. Rosenberg IH. Symposium: Sarcopenia: Diagnosis and Mechanisms Sarcopenia: Origins and Clinical Relevance 1. J Nutr. 1997;127:990-1.

  4. Walston JD. Musculoeskeletal system. En: Goldman-Cecil Medicine. Ventiséis. Elsevier; 2020. P. 104.

  5. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi, F, et al. Sarcopenia: European consensus on defi nition and diagnosis. Age Ageing. 2010;39(4):412-23.

  6. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7(5):512- 4.

  7. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm Y, et al. Sarcopenia: Revised European consensus on defi nition and diagnosis. Age Ageing. 2019;48(1):16-31.

  8. Beaudart C, Zaaria M, Pasleau F, Regnster JY, Bruyère O. Health outcomes of sarcopenia: A systematic review and meta-analysis. PLoS One. 2017;12(1):1-16.

  9. González KD. Envejecimiento Demográfi co en México. CONAPO [Internet]. 2015; Disponible en: http://www.conapo. gob.mx/work/models/CONAPO/Resource/2701/1/images/06_ envejecimiento.pdf

  10. Instituto de Información Estadística y Geográfi ca de Jalisco. Proyecciones de la Población de México y de las Entidades Federativas, 2016-2050. Strategos [Internet]. 2018;(71):68. Disponible en: https://www.iieg.gob.mx/contenido/ noticiasproyecciones-poblacion-jalisco-conpao-2016-2050 v2.pdf

  11. Instituto de Información Estadística y Geográfi ca de Jalisco. Los Adultos Mayores en Jalisco. Strategos [Internet]. 2019; Disponible en: https://iieg.gob.mx/contenido/PoblacionVivienda/ FichaAdultoMayor2019.pdf

  12. Espinel-Bermúdez MC, Sánchez-García S, García-Peña C, Trujillo X, Huerta-Viera M, Granados-García V, et al. Factores asociados a sarcopenia en adultos mayores mexicanos: Encuesta Nacional de Salud y Nutrición 2012. Rev Med Inst Mex Seguro Soc [Internet]. 2018;56(1):46-53. Disponible en: http://content.ebscohost.com/ContentServer.asp?- T=P&P=AN&K=129547063&S=R&D=a9h&EbscoContent=- dGJyMMvl7ESeqLI40dvuOLCmr1Cep7JSsqi4SbSWxWXS&- ContentCustomer=dGJyMPGnr0%2BzqrJMuePfgeyx44Dt- 6fIA

  13. Díaz-López E, Aranda M, Tapia B, Díaz C. Study of sarcopenia in a female Mexican population older than 50 years. Maturitas [Internet]. 2017;100(2017):195. Disponible en: http://dx.doi. org/10.1016/j.maturitas.2017.03.251

  14. Parra-Rodríguez L, Szlejf C, García González A, Malmstrom T, Cruz-Arenas E, Rosas-Carrasco O. Cross-Cultural Adaptation and Validation of the Spanish-Language Version of the SARC-F to Assess Sarcopenia in Mexican Community-Dwelling Older Adults. J Am Med Dir Assoc. 2016;17(12):1142-6.

  15. Steffl M, Bohannon RW, Sontakova L, Tufano JJ, Shiells K, Holmerova I. Relationship between sarcopenia and physical activity in older people: A systematic review and meta-analysis. Clin Interv Aging. 2017;12:835-45.

  16. Beaudart C, Dawson A, Shaw SC, Harvey NC, Kanis JA, Binkley N, et al. Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int. 2017;28(6):1817- 33.

  17. Steele JR, Coltman CE, McGhee DE. Eff ects of obesity on breast size, thoracic spine structure and function, upper torso musculoskeletal pain and physical activity in women. J Sport Heal Sci [Internet]. 2020;9(2):140-8. Disponible en: https://doi. org/10.1016/j.jshs.2019.05.003

  18. Farrance C, Tsofl iou F, Clark C. Adherence to community based group exercise interventions for older people: A mixed-methods systematic review. Prev Med (Baltim). 2016;87(2016):155-66.

  19. Dadgostar H, Firouzinezhad S, Ansaro M, Younespour S, Mahmoudpour A, Khamseh ME. Supervised group-exercise therapy versus home-based exercise therapy: Th eir eff ects on Quality of Life and cardiovascular risk factors in women with type 2 diabetes. Diabetes Metab Syndr Clin Res Rev [Internet]. 2016;10(2):S30-6. Disponible en: http://dx.doi.org/10.1016/j. dsx.2016.01.016

  20. Buckinx F, Landi F, Cesari M, Fielding RA, Visser M, Engelke K, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Chachexia Sarcopenia Muscle. 2018;9(2):269- 78.

  21. Wallengren O, Bosaeus I. Performance of a standing segmental bioimpedance device in screening for low muscle mass. Clin Nutr [Internet]. 2018;37(2018):S34-5. Disponible en: https://doi. org/10.1016/j.clnu.2018.06.1174

  22. Verreijen AM, van den Helder J, van Dronkelaar C, Memelink RG, Engberink MF, Weijs PJM, et al. Bio-electrical impedance analysis versus dual-energy x-ray absorptiometry. Clin Nutr [Internet]. 2018;37(2018):S102. Disponible en: https://doi.org/10.1016/j. clnu.2018.06.1392




2020     |     www.medigraphic.com